Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate West Pharmaceutical Services, Inc. before investing.

In this article, we go over a few key elements for understanding West Pharmaceutical Services, Inc.’s stock price such as:

• West Pharmaceutical Services, Inc.’s current stock price and volume
• Why West Pharmaceutical Services, Inc.’s stock price changed recently
• Upgrades and downgrades for WST from analysts
• WST’s stock price momentum as measured by its relative strength

About West Pharmaceutical Services, Inc. (WST)

Before we jump into West Pharmaceutical Services, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Want to learn more about West Pharmaceutical Services, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about West Pharmaceutical Services, Inc..

West Pharmaceutical Services, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, West Pharmaceutical Services, Inc.’s stock price was $340.960.

West Pharmaceutical Services, Inc. is up 0.4% from its previous closing price of $339.590.

During the last market session, West Pharmaceutical Services, Inc.’s stock traded between $334.380 and $342.750. Currently, there are approximately 70.80 million shares outstanding for West Pharmaceutical Services, Inc..

West Pharmaceutical Services, Inc.’s price-earnings (P/E) ratio is currently at 43.7, which is low compared to the Life Sciences Tools & Services industry median of 43.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

West Pharmaceutical Services, Inc. Stock Price History

West Pharmaceutical Services, Inc.’s (WST) price is currently down 5.03% so far this month.

During the month of July, West Pharmaceutical Services, Inc.’s stock price has reached a high of $386.000 and a low of $325.270.

Over the last year, West Pharmaceutical Services, Inc. has hit prices as high as $386.000 and as low as $223.830. Year to date, West Pharmaceutical Services, Inc.’s stock is up 23.92%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused West Pharmaceutical Services, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded West Pharmaceutical Services, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate West Pharmaceutical Services, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on West Pharmaceutical Services, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

West Pharmaceutical Services, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about West Pharmaceutical Services, Inc. (WST) by visiting AAII Stock Evaluator.

Relative Price Strength of West Pharmaceutical Services, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, West Pharmaceutical Services, Inc. has a weighted four-quarter relative price strength of 6.76%, which translates to a Momentum Score of 75 and is considered to be Strong.

Want to learn more about how West Pharmaceutical Services, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

West Pharmaceutical Services, Inc. Stock Price: Bottom Line

As of July 31, 2026, West Pharmaceutical Services, Inc.’s stock price is $340.960, which is up 0.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like West Pharmaceutical Services, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.